文献速递妇科

妊娠滋养细胞肿瘤误诊为异位妊娠:一项17年回顾性队列研究

GTN misdiagnosed as ectopic pregnancy: a 17-year retrospective cohort study.
PubMed 文献 · Gynecol Oncol · 2025-06-13

该回顾性队列研究纳入35例被误诊为异位妊娠的妊娠滋养细胞肿瘤(GTN)患者,按年龄、WHO风险评分和入院年份1:1匹配未误诊GTN作为对照。误诊组复发率显著高于对照组(28.6% vs 5.7%,p=0.011),耐药率呈升高趋势(22.9% vs 14.3%,p=0.356)。作者认为非葡萄胎妊娠后低hCG的GTN易被误诊,手术干预尤其病灶切除而非甲氨蝶呤被推荐用于不典型GTN。

要点

  • 误诊组中高危GTN占57.1%,前次非葡萄胎妊娠占88.6%。
  • 误诊组复发率显著高于对照组(28.6% vs 5.7%,p=0.011)。
  • 误诊组耐药率呈升高趋势(22.9% vs 14.3%,p=0.356)。

核心结论

  • 非葡萄胎妊娠后低hCG的GTN易被误诊,可能导致WHO风险评分升高、耐药和复发率增加。
  • 作者推荐对不典型GTN采用手术干预,尤其病灶切除而非甲氨蝶呤。

研究设计与样本

  • 回顾性队列研究,纳入被误诊为异位妊娠的GTN患者35例。
  • 未误诊GTN按年龄、WHO风险评分和入院年份1:1随机选取作为对照组。
  • 所有患者随访妊娠、复发和生存情况。
  • 连续变量采用Mann-Whitney检验,分类变量采用卡方检验或Fisher精确检验。

主要发现

  • 误诊组中高危GTN占57.1%,前次非葡萄胎妊娠占88.6%。
  • 误诊组治疗前hCG低于对照组(3477 vs 18121 IU/L)。
  • 误诊组复发率显著高于对照组(28.6% vs 5.7%,p=0.011)。
  • 误诊组耐药率呈升高趋势(22.9% vs 14.3%,p=0.356)。
  • 亚组分析中,甲氨蝶呤组(A组)耐药率高于非甲氨蝶呤组(B组),病灶切除组(C组)耐药率低于未切除组(D组),低危患者中尤为明显。

临床怎么用

  • 作者推荐对不典型GTN采用手术干预,尤其病灶切除而非甲氨蝶呤。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect of misdiagnosis on the chemotherapy response and prognosis of gestational trophoblastic neoplasia (GTN), and to explore strategies to enhance precision management of uncertain GTN. METHODS: GTN patients misdiagnosed as ectopic pregnancies were retrospectively enrolled. GTN without misdiagnosis were randomly selected as control group at a 1:1 ratio, matching by age, WHO risk score and admission year. All patients were followed up for pregnancy, recurrence, and survival. Mann-Whitney test was used for continuous variables. Categorical variables were assessed using the Chi-square test or Fisher's exact test. RESULTS: Among 35 misdiagnosed cases, high-risk GTN accounted for 57.1 %. Antecedent nonmolar pregnancy in misdiagnosed group was 88.6 %. Pretreatment human chorionic gonadotropin (hCG) was lower (3477 vs 18,121 IU/L) while recurrence rate was significantly higher in misdiagnosed group than in control group (28.6 % vs 5.7 %, p = 0.011). The resistance rate showed an increasing trend in misdiagnosed group (22.9 % vs 14.3 %, p = 0.356). For subgroup analysis, the resistance rate was increased in group A (treated with methotrexate) than group B (without methotrexate), while decreased in patients with lesion resection (group C) than without resection (group D), especially for low-risk patients. Histopathological misdiagnosis for antecedent pregnancy and GTN in primary hospitals were 2 and 6 cases respectively. CONCLUSIONS: GTN after nonmolar pregnancy with low hCG are prone to be misdiagnosed, which might lead to increased WHO risk scores, resistance, and relapse rates. Surgical intervention, especially lesion resection instead of methotrexate, is recommended for atypical GTN.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhou Y, Zhou Z, et al. GTN misdiagnosed as ectopic pregnancy: a 17-year retrospective cohort study. Gynecol Oncol. 2025. PMID: 40516205. doi:10.1016/j.ygyno.2025.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。